Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
104.09
+1.99 (1.95%)
Apr 9, 2026, 4:00 PM EDT - Market closed

Protagonist Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,6425,4662,3561,3235381,636
Market Cap Growth
105.97%131.99%78.04%145.83%-67.10%85.52%
Enterprise Value
6,0064,9061,947981.64302.081,313
Last Close Price
104.0987.3438.6022.9310.9134.20
PE Ratio
--42.609.13-16.50-4.20-12.62
Forward PE
34.7459.76----
PS Ratio
144.33118.785.4222.0520.2559.80
PB Ratio
10.608.893.493.932.505.45
P/TBV Ratio
10.769.033.723.872.485.28
P/FCF Ratio
118.4397.4612.89-18.68-4.94-15.01
P/OCF Ratio
115.1694.7712.79-18.84-4.98-15.17
EV/Sales Ratio
130.52106.624.4816.3611.3647.99
EV/EBITDA Ratio
--31.287.68-10.59-2.32-10.50
EV/EBIT Ratio
--31.037.70-10.48-2.30-10.43
EV/FCF Ratio
107.0987.4810.65-13.86-2.77-12.05
Debt / Equity Ratio
0.010.010.0200.010.01
Debt / EBITDA Ratio
-0.07-0.070.04-0.01-0.03-0.05
Debt / FCF Ratio
0.180.180.06-0.02-0.03-0.05
Net Debt / Equity Ratio
-0.91-0.91-0.60-1.01-1.08-1.07
Net Debt / EBITDA Ratio
3.553.55-1.613.671.792.57
Net Debt / FCF Ratio
-9.93-9.93-2.234.812.152.95
Asset Turnover
0.070.070.790.200.090.08
Quick Ratio
12.4912.4912.3216.537.617.53
Current Ratio
12.7112.7112.4816.717.807.74
Return on Equity (ROE)
-20.18%-20.18%54.39%-28.59%-49.41%-43.32%
Return on Assets (ROA)
-22.53%-22.53%45.17%-30.91%-44.11%-37.44%
Return on Invested Capital (ROIC)
-86.56%-86.56%167.86%855.66%700.45%1004.11%
Return on Capital Employed (ROCE)
-23.96%-23.96%48.91%-33.84%-50.49%-42.81%
Earnings Yield
-1.96%-2.35%10.96%-6.06%-23.83%-7.92%
FCF Yield
0.84%1.03%7.76%-5.35%-20.24%-6.66%
Buyback Yield / Dilution
2.31%2.31%-14.65%-15.74%-5.87%-34.67%
Total Shareholder Return
2.31%2.31%-14.65%-15.74%-5.87%-34.67%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q